CD79A and Epstein-Barr virus infection: To further investigate whether levels of antibody against EBV glycoproteins could reflect the ability of neutralization against EBV infection, first, we analyzed the correlation between IgG- and IgA-specific antibody targeting gp350, gH/gL, gB, and gp42 and the neutralizing activity in epithelial cells.